Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals
KE Chan, TJL Koh, ASP Tang, J Quek… - The Journal of …, 2022 - academic.oup.com
Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges
Over the past decade, there have been several guideline updates for the diagnosis and
management of non-alcoholic fatty liver disease (NAFLD), which is the most common …
management of non-alcoholic fatty liver disease (NAFLD), which is the most common …
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
XD Zhou, G Targher, CD Byrne, V Somers… - Hepatology …, 2023 - Springer
Background Fatty liver disease in the absence of excessive alcohol consumption is an
increasingly common condition with a global prevalence of~ 25–30% and is also associated …
increasingly common condition with a global prevalence of~ 25–30% and is also associated …
An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD
GEH Lim, A Tang, CH Ng, YH Chin, WH Lim… - Clinical …, 2023 - Elsevier
Background & Aims The shift to redefine nonalcoholic fatty liver disease (NAFLD) as
metabolic associated fatty liver disease (MAFLD) can profoundly affect patient care, health …
metabolic associated fatty liver disease (MAFLD) can profoundly affect patient care, health …
Obesity and diabetes
C Boutari, A DeMarsilis, CS Mantzoros - Diabetes Research and Clinical …, 2023 - Elsevier
Obesity, which has currently reached pandemic dimensions, is usually accompanied by
diabetes mellitus type 2 (T2DM). These two conditions share common pathophysiological …
diabetes mellitus type 2 (T2DM). These two conditions share common pathophysiological …
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic …
Non-alcoholic fatty liver disease (NAFLD) is a prevalent metabolic condition closely
associated with genetic predisposition and/or obesity, lipodystrophy, and insulin resistance …
associated with genetic predisposition and/or obesity, lipodystrophy, and insulin resistance …
Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12 620 736 individuals
Objective The recent introduction of the term metabolic associated fatty liver disease
(MAFLD) sought to reclassify nonalcoholic fatty liver disease (NAFLD). MAFLD is thought to …
(MAFLD) sought to reclassify nonalcoholic fatty liver disease (NAFLD). MAFLD is thought to …
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
The definition of “Metabolic Associated Fatty Liver Disease–MAFLD” has replaced the
previous definition of Nonalcoholic Fatty Liver Disease (NAFLD), because cardiometabolic …
previous definition of Nonalcoholic Fatty Liver Disease (NAFLD), because cardiometabolic …
Severity and Remission of Metabolic Dysfunction–Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence
J Gao, Y Li, Y Zhang, X Zhan, X Tian, J Li… - Journal of the …, 2024 - ahajournals.org
Background The association of the severity of hepatic steatosis in metabolic dysfunction–
associated fatty liver disease (MAFLD)/metabolic dysfunction–associated steatotic liver …
associated fatty liver disease (MAFLD)/metabolic dysfunction–associated steatotic liver …
Statins' efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysis
C Boutari, PD Pappas, D Anastasilakis, CS Mantzoros - Clinical Nutrition, 2022 - Elsevier
Background & aims Non-alcoholic fatty liver disease (NAFLD) is closely related with the
metabolic syndrome and cardiovascular disease. Currently there is no approved medication …
metabolic syndrome and cardiovascular disease. Currently there is no approved medication …